Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel metal-free method for 3-selenoindoles using NFSI. High yield, scalable process for pharmaceutical intermediates manufacturing.
Patent CN108033919B details a novel Pd-catalyzed oxidative cleavage route using styrenes, offering cost-effective manufacturing for high-purity pharmaceutical intermediates.
Discover the novel one-step Suzuki coupling route for 5-chloro-2-(pyridin-3-yl)pyridin-3-amine. High yield, scalable process for pharmaceutical intermediate manufacturing.
Patent CN115611726A details a metal-free method for cyclic ketone ring-opening. Achieve high-purity carboxylic acids with significant cost reduction in fine chemical manufacturing.
Advanced synthesis of AMN107 oxidative degradation impurity via patent CN107188887A. Ensures high-purity standards and cost reduction in pharmaceutical intermediate manufacturing.
Novel trifluorosulfonate catalyzed route for N-sulfonyl tetrahydro-beta-carboline derivatives. High yield, scalable process for pharmaceutical intermediate manufacturing.
Patent CN102432496A details an acidic recrystallization method for carbidopa, ensuring high purity and yield. Discover cost-effective manufacturing solutions.
Novel patent CN106083839B details a high-purity Dasatinib preparation method offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102731357B details a water-based synthesis for N,N'-dicyclohexylthiourea, offering >99% yield and eliminating toxic organic solvents for safer API manufacturing.
Novel oxidation method for Epinastine Impurity A ensures >95% purity. Cost-effective process for pharmaceutical quality control and supply chain stability.
Patent CN119176776A reveals a novel Lewis acid-catalyzed route for beta-lactamase inhibitor intermediates, offering high selectivity and simplified purification for reliable supply chains.
Patent CN102826985B details a high-yield 3-step synthesis for pharmaceutical intermediates. Discover cost-effective scaling and purity advantages for your supply chain.
Patent CN116730915A enables metal-free asymmetric catalysis. Offers high purity pharmaceutical intermediates with reduced cost and scalable supply chain solutions.
Patent CN111217756B reveals a safer, scalable route for dexmedetomidine hydrochloride, eliminating high-risk hydrogenation and complex protection steps for reliable supply.
Patent CN107915649B details a rhodium-catalyzed route to tetrahydronaphthalene derivatives, offering high selectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel N-monosulfonated chiral diamines enable efficient aqueous phase asymmetric hydrogenation, reducing solvent waste and costs for API intermediates.
Advanced preparation of Relugolix Impurity I and II via novel condensation and cyclization. Enhances QC reliability and reduces API manufacturing costs significantly.
Patent CN1123570C reveals a novel carbonylation route for 4-hydroxybenzothiophene, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113444125A reveals high-ee ligand for alkaloid synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable supply chain reliability.
Novel patent CN118271161A enables high-purity pharmaceutical intermediate production with significantly reduced costs and scalable processes for global supply chains ensuring continuity.